Clinical Trial Update: Study Evaluating Sirolimus in Kidney Transplant Recipients in India [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating sirolimus in kidney transplant recipients in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Graft-versus-host Disease

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Failure, Graft vs Host Disease | Phase 4 | Status: COMPLETED